معرفی
Professor Nagy Habib is a Professor of Hepatobiliary Surgery at Imperial College London's Department of Surgery & Cancer within the Faculty of Medicine. He is an active surgeon specializing in liver, pancreas, and biliary system surgeries, and a translational researcher focusing on liver cancer treatment and regenerative medicine. His pioneering work includes clinical trials in gene therapy, stem cell therapy, and surgical innovations like the Habib 4X device and Habib EndoHPB, which have been commercialized by major companies.
- Educations:
- MBBCh, Ein Shams Medical University, Cairo, Egypt (1972–1977)
- ChM, University of Bristol, United Kingdom (1988–1995)
- FRCS, Royal College of Surgeons of Edinburgh (1981–present)
His research interests span hepatobiliary surgery, oncology, medical biotechnology, and immunology. He has founded companies such as EMcision, MiNA Therapeutics, and Dawn Therapeutics to advance medical innovations. Notable achievements include performing the first living-related liver transplant in Africa/Middle East (1993) and inventing devices recognized with a Vatican advisory role and Edison Gold Award (2020).
Awards include the Takreem Laureate (2012) and election to the French Académie Nationale de Chirurgie (2015). He holds honorary professorships in multiple countries and advises on regenerative medicine's cultural impact.
